Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
44-48 |
CHEBI_50906 |
denotes |
role |
T1 |
56-63 |
DOID_4 |
denotes |
disease |
T2 |
64-72 |
HP_0012824 |
denotes |
severity |
T3 |
90-98 |
DOID_0080600 |
denotes |
COVID-19 |
T4 |
267-278 |
CHEBI_64360 |
denotes |
tocilizumab |
T5 |
404-412 |
DOID_0080600 |
denotes |
COVID-19 |
T6 |
503-514 |
CHEBI_64360 |
denotes |
tocilizumab |
T7 |
584-592 |
HP_0012826 |
denotes |
moderate |
T8 |
596-602 |
HP_0012828 |
denotes |
severe |
T9 |
603-611 |
DOID_0080600 |
denotes |
COVID-19 |
T10 |
736-744 |
CHEBI_82594 |
denotes |
ferritin |
T12 |
930-938 |
DOID_0080600 |
denotes |
COVID-19 |
T14 |
1562-1583 |
GO_0006954 |
denotes |
inflammatory response |
T15 |
1587-1595 |
DOID_0080600 |
denotes |
COVID-19 |
R0 |
T14 |
T2 |
no_relation |
inflammatory response,severity |
R1 |
T14 |
T7 |
no_relation |
inflammatory response,moderate |
R10 |
T3 |
T6 |
effect |
COVID-19,tocilizumab |
R11 |
T3 |
T10 |
effect |
COVID-19,ferritin |
R13 |
T5 |
T0 |
no_relation |
COVID-19,role |
R14 |
T5 |
T4 |
effect |
COVID-19,tocilizumab |
R15 |
T5 |
T6 |
effect |
COVID-19,tocilizumab |
R16 |
T5 |
T10 |
effect |
COVID-19,ferritin |
R18 |
T9 |
T0 |
no_relation |
COVID-19,role |
R19 |
T9 |
T4 |
effect |
COVID-19,tocilizumab |
R2 |
T14 |
T8 |
no_relation |
inflammatory response,severe |
R20 |
T9 |
T6 |
effect |
COVID-19,tocilizumab |
R21 |
T9 |
T10 |
effect |
COVID-19,ferritin |
R23 |
T12 |
T0 |
no_relation |
COVID-19,role |
R24 |
T12 |
T4 |
effect |
COVID-19,tocilizumab |
R25 |
T12 |
T6 |
no_relation |
COVID-19,tocilizumab |
R26 |
T12 |
T10 |
no_relation |
COVID-19,ferritin |
R28 |
T15 |
T0 |
no_relation |
COVID-19,role |
R29 |
T15 |
T4 |
effect |
COVID-19,tocilizumab |
R30 |
T15 |
T6 |
no_relation |
COVID-19,tocilizumab |
R31 |
T15 |
T10 |
no_relation |
COVID-19,ferritin |
R4 |
T1 |
T4 |
effect |
disease,tocilizumab |
R5 |
T1 |
T6 |
effect |
disease,tocilizumab |
R6 |
T1 |
T10 |
effect |
disease,ferritin |
R8 |
T3 |
T0 |
no_relation |
COVID-19,role |
R9 |
T3 |
T4 |
effect |
COVID-19,tocilizumab |